FLT3 ligand fusion proteins and methods of use

The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.

Saved in:
Bibliographic Details
Main Authors BAINBRIDGE, TRAVIS WILLIAM, KEMBALL, CHRISTOPHER CHARLES, SCHARTNER, JILL M, LIU, YICHIN, LAZAR, GREGORY ALAN, HOSSEINI, IRAJ, MOUSSION, CHRISTINE CARINE, COHEN, SIVAN
Format Patent
LanguageChinese
English
Published 01.06.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
AbstractList The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
Author MOUSSION, CHRISTINE CARINE
KEMBALL, CHRISTOPHER CHARLES
HOSSEINI, IRAJ
LAZAR, GREGORY ALAN
SCHARTNER, JILL M
LIU, YICHIN
COHEN, SIVAN
BAINBRIDGE, TRAVIS WILLIAM
Author_xml – fullname: BAINBRIDGE, TRAVIS WILLIAM
– fullname: KEMBALL, CHRISTOPHER CHARLES
– fullname: SCHARTNER, JILL M
– fullname: LIU, YICHIN
– fullname: LAZAR, GREGORY ALAN
– fullname: HOSSEINI, IRAJ
– fullname: MOUSSION, CHRISTINE CARINE
– fullname: COHEN, SIVAN
BookMark eNrjYmDJy89L5WTQc_MJMVbIyUxPzEtRSCstzszPUygoyi9JzcwrVgCJ5aaWZOSnFCvkpymUFqfyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JL4kHAjAyMjI0MDQzNHY2LUAACXHCug
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW202221016A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW202221016A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:01:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW202221016A3
Notes Application Number: TW202110128976
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220601&DB=EPODOC&CC=TW&NR=202221016A
ParticipantIDs epo_espacenet_TW202221016A
PublicationCentury 2000
PublicationDate 20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: 20220601
  day: 01
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies GENENTECH, INC
RelatedCompanies_xml – name: GENENTECH, INC
Score 3.53246
Snippet The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title FLT3 ligand fusion proteins and methods of use
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220601&DB=EPODOC&locale=&CC=TW&NR=202221016A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTc3NjE2S7EArRI3A3ZQgOVgolFysq6xZaJBookZMElbgnYj-_qZeYSaeEWYRjAxZMH2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO_YyAh0vIiai5Ota4C_i7-zmrOzbUi4ml8QWM4I1FN1ZGZgBTWjQefsu4Y5gXalFCBXKW6CDGwBQNPySoQYmKoyhBk4nWE3rwkzcPhCJ7yBTGjeKxZh0HPzCTFWyMlMB_b9FdJKQaNcCuBTFjLzihVAYpDLoIsV8tMUSotTRRkU3VxDnD10gRbHw30ZHxKOcKOxGAMLsPefKsGgYGaQZmhkbphmYZkE7EklpiYmpRkbJZuYG5ikJFlaJBlJMkjhNkcKn6Q0AxeIA1n3JMPAUlJUmioLrGFLkuTAQQMAMxt9xw
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTc3NjE2S7EArRI3A3ZQgOVgolFysq6xZaJBookZMElbgnYj-_qZeYSaeEWYRjAxZMH2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO_YyAh0vIiai5Ota4C_i7-zmrOzbUi4ml8QWM4I1FN1ZGZgBTrAANxVCnMC7UopQK5S3AQZ2AKApuWVCDEwVWUIM3A6w25eE2bg8IVOeAOZ0LxXLMKg5-YTYqyQk5kO7PsrpJWCRrkUwKcsZOYVK4DEIJdBFyvkpymUFqeKMii6uYY4e-gCLY6H-zI-JBzhRmMxBhZg7z9VgkHBzCDN0MjcMM3CMgnYk0pMTUxKMzZKNjE3MElJsrRIMpJkkMJtjhQ-SXkGTo8QX594H08_b2kGLpAEZA2UDANLSVFpqiywti1JkgMHEwA5yYCx
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FLT3+ligand+fusion+proteins+and+methods+of+use&rft.inventor=BAINBRIDGE%2C+TRAVIS+WILLIAM&rft.inventor=KEMBALL%2C+CHRISTOPHER+CHARLES&rft.inventor=SCHARTNER%2C+JILL+M&rft.inventor=LIU%2C+YICHIN&rft.inventor=LAZAR%2C+GREGORY+ALAN&rft.inventor=HOSSEINI%2C+IRAJ&rft.inventor=MOUSSION%2C+CHRISTINE+CARINE&rft.inventor=COHEN%2C+SIVAN&rft.date=2022-06-01&rft.externalDBID=A&rft.externalDocID=TW202221016A